CareerExamPro

ONCC ROCN, AACN CMC/CSC, NCC C-OBE, BPS BCPMP & FMCSA NRCME (2026) Practice Test

2026 new & revised clinical boards: ONCC Radiation Oncology (ROCN), AACN Cardiac Medicine/Surgery (CMC/CSC), Obstetric Emergencies (C-OBE), BPS Pain Management (BCPMP), FMCSA NRCME DOT physicals, and 2026 NCLEX/PTCB updates.

40 questions · 2 topics · start free, no sign-up

Start practising

Mixed practice drill

10 realistic exam questions, graded as you go, with the exact rule or statute citation for every answer. Start free, no sign-up.

Timed mock exam

40 questions in 48 minutes, drawn from every topic. No answers shown until the end, then a full score breakdown, your weakest topics and a review of what you missed.

Practise by topic

Sample questions

A CMV driver with stable congenital amblyopia tests at 20/25 distant visual acuity and 85 degrees horizontal field of vision in the right eye, 20/100 in the left eye, and normal traffic signal color recognition. He brings a Vision Evaluation Report (Form MCSA-5871) signed by his optometrist 20 days ago. Which statement accurately reflects certification under the FMCSA Alternative Vision Standard (49 CFR 391.44)?

  1. The driver is permanently disqualified from interstate CMV operation because 49 CFR 391.41 requires at least 20/40 Snellen acuity in both eyes with no exceptions.
  2. The Medical Examiner may issue a 2-year medical certificate immediately, and the driver is exempt from any motor carrier road test requirement.
  3. The driver may be certified for up to 1 year within 45 days of Form MCSA-5871, and must also complete a motor carrier road test unless excepted.
  4. The Medical Examiner must defer certification until the driver obtains a 2-year Federal Vision Exemption directly from FMCSA before returning.
Show the answer

C. The driver may be certified for up to 1 year within 45 days of Form MCSA-5871, and must also complete a motor carrier road test unless excepted.

While standard vision qualification (49 CFR 391.41(b)(10)) requires >=20/40 Snellen acuity and >=70 degrees horizontal field in each eye plus color recognition, the Alternative Vision Standard (49 CFR 391.44) allows drivers with stable monocular or worse-eye <20/40 vision to qualify if their better eye meets >=20/40 and >=70 degrees. An ophthalmologist or optometrist completes Form MCSA-5871, the ME conducts the exam within 45 days for a maximum 1-year certificate, and the driver must pass a motor carrier road test (unless meeting specific prior-experience exceptions).

Reference: 49 CFR 391.41(b)(10) & 49 CFR 391.44 (Alternative Vision Standard, Form MCSA-5871)

A 9-year-old child with a posterior fossa medulloblastoma is scheduled for craniospinal irradiation. The radiation oncology team selects proton beam therapy over photon-based intensity-modulated radiation therapy (IMRT). Which dosimetric property of proton beams primarily explains this clinical advantage?

  1. Protons exhibit exponential depth-dose attenuation beyond the target, creating a wider low-dose exit bath that sterilizes microscopic subclinical disease.
  2. Protons possess higher linear energy transfer than alpha particles, allowing single-fraction tumor ablation without requiring daily image-guided immobilization.
  3. Protons deposit peak energy at a finite depth (the Bragg peak) with virtually no distal exit dose, sparing anterior organs such as the heart, lungs, and bowel.
  4. Protons bypass superficial skin entirely with zero entrance dose, completely eliminating acute radiation dermatitis regardless of beam energy or field size.
Show the answer

C. Protons deposit peak energy at a finite depth (the Bragg peak) with virtually no distal exit dose, sparing anterior organs such as the heart, lungs, and bowel.

Charged proton particles deliver a relatively low entrance dose, release maximum ionizing energy at a predictable, energy-dependent depth known as the Bragg peak (spread across the tumor via a spread-out Bragg peak), and drop abruptly to virtually zero exit dose distally. In pediatric craniospinal irradiation, eliminating exit dose dramatically reduces integral radiation exposure to anterior developing tissues (heart, lungs, thyroid, GI tract, and gonads) compared with megavoltage photon IMRT, which still delivers an exit dose bath.

Reference: ONCC ROCN 2026 Blueprint (Radiation Physics & Modalities) / ASTRO Proton Beam Therapy Model Policy

A CMV driver fails the forced whisper test at 5 feet in both ears and undergoes pure-tone audiometry (ISO standard) without hearing aids:

TEXT
Frequency:   500 Hz   1,000 Hz   2,000 Hz   4,000 Hz
Right ear:    35 dB     40 dB      40 dB      65 dB
Left ear:     50 dB     55 dB      60 dB      70 dB

Applying 49 CFR 391.41(b)(11), does this driver meet the federal DOT hearing standard?

  1. No, because the right ear's 4-frequency average across 500, 1,000, 2,000, and 4,000 Hz is 45.0 dB, exceeding the 40 dB regulatory limit.
  2. Yes, because the better (right) ear averages 38.3 dB across 500, 1,000, and 2,000 Hz, meeting the 40 dB or less threshold in at least one ear.
  3. No, because FMCSA regulations require both ears independently to demonstrate an average hearing loss of 40 dB or less across 500 to 2,000 Hz.
  4. No, because failing the initial forced whisper test at 5 feet automatically disqualifies a driver regardless of pure-tone audiometry thresholds.
Show the answer

B. Yes, because the better (right) ear averages 38.3 dB across 500, 1,000, and 2,000 Hz, meeting the 40 dB or less threshold in at least one ear.

Under 49 CFR 391.41(b)(11), a driver passes the hearing standard by meeting EITHER the forced whisper test (>=5 feet) OR audiometry in at least ONE (better) ear. Audiometric qualification uses the 3-frequency average at 500 Hz, 1,000 Hz, and 2,000 Hz (4,000 Hz is excluded). Here, the right ear averages (35 + 40 + 40) / 3 = 115 / 3 = 38.3 dB, which is <=40 dB, so the driver passes without needing a hearing aid or federal hearing exemption.

Reference: 49 CFR 391.41(b)(11) (Physical Qualifications for Drivers — Hearing Standard)

A 64-year-old patient with endometrial cancer completes an outpatient high-dose-rate (HDR) vaginal cuff brachytherapy fraction delivered via an iridium-192 remote afterloader. After the applicator is removed and a Geiger-Mueller survey confirms background radiation levels, the patient asks whether she must stay separated from her infant grandchild tonight. How should the nurse respond?

  1. Maintain a minimum distance of six feet from infants and pregnant individuals for at least 72 hours while residual gamma radiation decays from the vaginal mucosa.
  2. Flush the toilet twice after every void and wash personal linens separately for seven days to prevent body-fluid radiation contamination at home.
  3. Sleep in a separate bedroom for two weeks and wear a lead-impregnated undergarment when holding children under age five during the first month.
  4. No radiation isolation precautions are needed after discharge because the HDR source is fully retracted and no radioactivity remains in the body.
Show the answer

D. No radiation isolation precautions are needed after discharge because the HDR source is fully retracted and no radioactivity remains in the body.

HDR brachytherapy uses a high-activity sealed source (typically Ir-192) delivered briefly through an applicator inside a shielded vault via a remote afterloader. Once the source retracts back into the safe and the mandatory post-treatment radiation survey confirms background readings, the patient retains zero radioactivity and poses no radiation hazard to family members, infants, or pregnant individuals. Isolation or distance precautions apply to permanent LDR implants (e.g., I-125/Pd-103 seeds) or unsealed systemic radiopharmaceuticals (e.g., I-131), not HDR treatments.

Reference: ONCC ROCN 2026 Blueprint (Brachytherapy Safety) / NRC 10 CFR 35.604 & ONS Clinical Practice Resources

A CMV driver previously diagnosed with severe obstructive sleep apnea (baseline AHI 42 events/hr) returns for annual DOT recertification bringing a 90-day electronic CPAP adherence report. Which objective CPAP compliance metric satisfies standard FMCSA Medical Examiner's Handbook guidance for up to a 1-year recertification?

  1. CPAP usage of at least 2 hours per night on at least 50% of nights, provided the driver reports no daytime sleepiness on the Epworth Sleepiness Scale.
  2. CPAP usage of at least 6 hours per night on 100% of nights with zero missed days during the preceding 90-day monitoring window.
  3. Self-reported nightly CPAP adherence documented in the driver's personal sleep diary without requiring an electronic machine data download.
  4. Objective CPAP usage of at least 4 hours per night on at least 70% of nights with controlled AHI and resolution of daytime sleepiness.
Show the answer

D. Objective CPAP usage of at least 4 hours per night on at least 70% of nights with controlled AHI and resolution of daytime sleepiness.

Under FMCSA Medical Examiner's Handbook guidance for obstructive sleep apnea (49 CFR 391.41(b)(5) respiratory dysfunction), minimally acceptable objective PAP compliance is at least 4 hours of use per night on at least 70% of nights (verified by electronic device download), accompanied by controlled residual AHI and absence of excessive daytime sleepiness, permitting certification for a maximum of 1 year. Self-reported adherence alone is insufficient.

Reference: 49 CFR 391.41(b)(5) / FMCSA Medical Examiner's Handbook (Obstructive Sleep Apnea & PAP Compliance)

Exams this helps with

ExamAgency / IssuerRegion
FMCSA NRCME Certified Medical Examiner (2026 DOT Guidelines)FMCSA / DOTUnited States
BPS Board Certified Pain Management Pharmacist (BCPMP)BPSUnited States
2026 NCLEX-RN Clinical Judgment & PTCB DSCSA Federal BlueprintNCSBN / PTCBUnited States
ONCC Radiation Oncology Certified Nurse (ROCN — 2026 Launch)ONCCUnited States
AACN Cardiac (CMC / CSC Nov 2026) & NCC Obstetric Emergencies (C-OBE)AACN / NCCUnited States